Onderneming Atea Pharmaceuticals, Inc.
Aandelen
AVIR
US04683R1068
Biotechnologie & Medisch Onderzoek
Geschatte realtime
Andere beurzen
|
Variatie 5 dagen | Verschil t.o.v. 1 jan (%) | ||
3,875 USD | +4,73% | +5,00% | +27,38% |
Vakgebied
Aantal werknemers: 75
Managers
Managers | Titel | Leeftijd | Van |
---|---|---|---|
Chief Executive Officer | 68 | 01-12-12 | |
Andrea Corcoran
DFI | Director of Finance/CFO | 61 | 01-12-13 |
Maria Horga
CTO | Chief Tech/Sci/R&D Officer | 55 | 01-08-20 |
Chief Tech/Sci/R&D Officer | - | - | |
Jonae R. Barnes
IRC | Investor Relations Contact | - | 19-01-21 |
Brian Rowe
PRN | Corporate Officer/Principal | - | - |
Laura Ishak
PRN | Corporate Officer/Principal | - | - |
Jayanthi Wolf
LAW | General Counsel | - | 19-01-21 |
Wayne Foster
AUD | Comptroller/Controller/Auditor | 55 | 01-12-19 |
Sales & Marketing | - | - |
Besturend
Besturend | Titel | Leeftijd | Van |
---|---|---|---|
Franklin Berger
BRD | Director/Board Member | 74 | 01-09-19 |
Barbara Duncan
BRD | Director/Board Member | 59 | 01-10-20 |
Chief Executive Officer | 68 | 01-12-12 | |
Bruno Lucidi
BRD | Director/Board Member | 64 | 01-09-14 |
Bruce Polsky
BRD | Director/Board Member | 70 | 01-11-14 |
Polly Murphy
BRD | Director/Board Member | 59 | 01-08-20 |
Jerome Adams
BRD | Director/Board Member | 49 | 20-05-21 |
Aandelenklasse
Stemming | Aantal | Vrij verhandelbaar | Bedrijfseigen aandelen | Drijvend Totaal | |
---|---|---|---|---|---|
Aandeel A | 1 | 84 223 100 | 76 199 232 ( 90,47 %) | 0 | 90,47 % |
Bedrijfsgegevens
Sector
Herzieningen van WPA
Vaira. 1 jan. | Kapi. | |
---|---|---|
+27,38% | 312 mln. | |
-0,60% | 102 mld. | |
+3,43% | 96,09 mld. | |
+2,13% | 22,28 mld. | |
-14,64% | 21,4 mld. | |
-8,79% | 18,14 mld. | |
-39,98% | 17,02 mld. | |
-13,08% | 16,09 mld. | |
+8,09% | 13,83 mld. | |
+35,93% | 11,97 mld. |
- Beurs
- Aandelen
- Koers AVIR
- Onderneming Atea Pharmaceuticals, Inc.